Author: Kayla Hui

Combating Diabetes Disparities Among The Hispanic Population

At ADA 2021, David Marrero discusses how culturally tailored care can combat diabetes disparities among the Hispanic population.

Walmart Launches Lower-Cost Analog Insulin: ReliOn NovoLog

ReliOn NovoLog will be available at Walmart and Sam's Club pharmacies for $72.88 per vial and $85.88 per box of five FlexPens.

Effects of Medicaid Coverage on the Diabetes Prevention Program in California

Obidiugwu K. Duru presents at the 81st ADA conference on how medicaid impacts the California Diabetes Prevention Program.

Zegalogue® Is Now Commercially Available in the United States

Zegalogue®, also known as dasiglucagon, is now commercially available in the U.S. for the treatment of severe hypoglycemia.

Medicare Loosens Restrictions On Continuous Glucose Monitor Coverage

Medicare revised its local coverage determination policy to remove requirements for continuous glucose monitor coverage.

Supreme Court Votes To Keep The ACA Intact

The Affordable Care Act (ACA) provides health care to millions of Americans. The Supreme Court voted 7-2 to keep the ACA intact.

Michelle L. Litchman Focuses On Diabetes Program Accessibility For People Who Are Deaf

Michelle L. Litchman was named a Betty Irene Moore Nurse Fellow. She will focus on diabetes program accessibility for people who are deaf.

Omnipod 5 Pivotal Trial Data Published

Data from the pivotal trial shows that the Omnipod 5 improves time-in-range, and reduces HbA1c and mean glucose levels.

ATTD 2021: Lessons About Diabetes During The COVID-19 Pandemic

ATTD 2021 took place from June 2-5. Dr. Irl Hirsch shares his lessons about diabetes during the COVID-19 pandemic.

Breaking News From ATTD 2021

This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.